Vish Kulkarni

Building consumer & enterprise solutions that drive $100M+ outcomes | Product Leader | Samsung | Danaher | AI/ML | Kellogg MBA

📍 United States🔄 Updated September 2026💼 1 investments📅 6 years investing🗓 Last invested Jan 2020
VC🌍 United States
1
Total investments
0
Early stage
0
Mid stage
0
Late stage
6y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Advisor / Investor
2020
Various board memberships
Experience · 4 entries
All (4)
Investments (1)
Founder (1)
2024
Product, Tech Strategy and Partnerships (Mobile, AI, Health)
2024
Samsung Electronics is a global leader in technology, opening new possibilities for people everywhere. Through relentless innovation and discovery, we are transforming the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems, medical devices, semiconductors and LED solutions. Samsung is also leading in the Internet of Things space through, among others, our Smart Home and Digital Health initiatives. Since being established in 1969, Samsung Electronics has grown into one of the world’s leading technology companies, and become recognized as one of the top 10 global brands. Our network now extends across the world, and Samsung takes great pride in the creativity and diversity of its talented people, who drive our growth. To discover more, please visit our website at www.samsung.com and our official newsroom at news.samsung.com
2023
Venture Scout
2023
Founded in 2014, we’re America’s largest venture firm for individual investors and VC investing partner to over 11,000 individuals and institutions. Offerings include institutional-grade funds with large diversified portfolios and deal-by-deal investing through our Syndicates. Investment minimum is $10,000. • Top-20 VC Firm (Time Magazine ’25) • Top-Decile Investment Performance (Carta Benchmarks ‘25) • Top 20 VC Firm (CB Insights 24) • Top 50 Unicorn VC (Stanford GSB Research ‘25) • Top 3 Most Active US VC Firm (PitchBook ‘18 - ‘24) • Most Founder Friendly Investor List (Inc. Magazine ‘24) • Worlds Most Innovative Companies (Fast Company 22) • #1 Most Active Venture Firm in the US (PitchBook 22 & 23) • Top 20 Venture Firm (CB Insights 24) • Worlds Most Innovative Companies (Fast Company 22) • Portfolio of 1,600+ current and historical companies • 40+ full-time VC investors • Founders get access to our community of 850,000+ members and 6,000+ Experts. Offers of securities made only to eligible investors by formal offering documents describing risks, terms, and other important information that must be considered before investing. Example portfolio companies shown for illustrative purposes only, do not necessarily reflect investment outcomes that were or would be obtained by any AV fund or investor, and are not available to future investors, except potentially in follow-on investments. Venture capital investing involves substantial risk, including risk of loss of all capital invested. Past performance does not guarantee future results. The content on this account is intended solely for persons located in the U.S. and is not directed at, and must not be acted upon, by any person in the United Kingdom. UK residents seeking information about AV should refer only to communications issued by Alumni Ventures UK LLP, which provides information solely on a non-promotional basis and only distributes Financial Promotions to eligible recipients in accordance with UK law.
2021
Co-Founder
2021
MediKarma is a Gen AI-powered health and wellness assistant in a user-friendly mobile app. MediKarma analyzes your medical history and live data from smart devices to create hyper-personalized wellness plans, providing insights and recommendations to unlock healthy habits and support a longer, healthier life. MediKarma empowers Payors, HMOs, and Self-Insured Organizations by providing a data-driven platform that can align their financial goals with improved patient outcomes, supporting the transition to value-based care. By leveraging advanced generative AI technology, MediKarma can help these organizations optimize resource utilization, enhance care delivery, and reduce overall costs. The platform focuses on value-based care, which enables advantages such as better care coordination, fewer hospital readmissions, and improved health outcomes through personalized, proactive interventions. It offers actionable insights into population health trends, enabling targeted management of high-risk individuals and encouraging preventive care for low-risk populations. By fostering greater member engagement, MediKarma can potentially drive healthier, more satisfied patients, which may lead to lower claims expenses and improved revenue margins. Through these efforts, MediKarma positions its partners to deliver value-based healthcare solutions that prioritize quality and cost-effectiveness.
2020
Advisor / Investor
2020
Various board memberships